News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,010 Results
Type
Article (62317)
Company Profile (290)
Press Release (624403)
Section
Business (186477)
Career Advice (2794)
Deals (34626)
Drug Delivery (102)
Drug Development (83731)
Employer Resources (159)
FDA (15980)
Job Trends (14841)
News (328486)
Policy (31735)
Tag
Academia (2793)
Alliances (46687)
Alzheimer's disease (1370)
Approvals (15934)
Artificial intelligence (158)
Bankruptcy (302)
Best Places to Work (11732)
Biotechnology (194)
Breast cancer (193)
Cancer (1445)
Cardiovascular disease (122)
Career advice (2356)
CAR-T (107)
Cell therapy (315)
Clinical research (66620)
Collaboration (509)
Compensation (247)
COVID-19 (2702)
C-suite (121)
Data (1427)
Diabetes (180)
Diagnostics (6337)
Earnings (66730)
Employer resources (140)
Events (106284)
Executive appointments (420)
FDA (16706)
Funding (452)
Gene therapy (218)
GLP-1 (651)
Government (4723)
Healthcare (19396)
Infectious disease (2802)
Inflammatory bowel disease (126)
Interviews (529)
IPO (16051)
Job creations (3556)
Job search strategy (1986)
Layoffs (468)
Legal (6924)
Lung cancer (214)
Manufacturing (201)
Medical device (13107)
Medtech (13112)
Mergers & acquisitions (18803)
Metabolic disorders (479)
Neuroscience (1721)
NextGen Class of 2024 (6835)
Non-profit (4781)
Northern California (1682)
Obesity (268)
Opinion (227)
Patents (125)
People (59209)
Phase I (20636)
Phase II (29248)
Phase III (21835)
Pipeline (522)
Postmarket research (2836)
Preclinical (9051)
Radiopharmaceuticals (254)
Rare diseases (293)
Real estate (6094)
Regulatory (21646)
Research institute (2504)
Resumes & cover letters (426)
Southern California (1456)
Startups (3510)
United States (15339)
Vaccines (633)
Weight loss (197)
Date
Last 7 days (172)
Last 30 days (1650)
Last 365 days (34752)
2025 (95)
2024 (35485)
2023 (39824)
2022 (50894)
2021 (55694)
2020 (54442)
2019 (47724)
2018 (36235)
2017 (32889)
2016 (32478)
2015 (37932)
2014 (30928)
2013 (26810)
2012 (28360)
2011 (28538)
2010 (27290)
Location
Africa (933)
Arizona (148)
Asia (40127)
Australia (7132)
California (3814)
Canada (1428)
China (325)
Colorado (173)
Connecticut (188)
Europe (93396)
Florida (548)
Georgia (134)
Illinois (418)
Indiana (226)
Maryland (646)
Massachusetts (2962)
Michigan (184)
Minnesota (280)
New Jersey (1146)
New York (1096)
North Carolina (812)
Northern California (1682)
Ohio (147)
Pennsylvania (908)
South America (1289)
Southern California (1456)
Texas (560)
Utah (110)
Washington State (404)
687,010 Results for "infectious diseases society of america idsa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Matinas BioPharma Announces Infectious Diseases Society of America (IDSA) has Selected the EnACT Phase 2 Trial Abstract of MAT2203 as its Outstanding Abstract and IDSA Awardee For IDWeek 2022
Matinas BioPharma Holdings, Inc. today announced that the Infectious Diseases Society of America (IDSA), one of the four sponsoring societies for IDWeek 2022.
October 19, 2022
·
6 min read
Infectious disease
J&J Discontinues Phase II Dengue Study as it Retreats from Infectious Disease
J&J has recently pulled back from the infectious diseases space, including winding down R&D activity in this area in August 2023.
October 7, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Sumitomo Pharma America Presents New Data on Nuvisertib and Enzomenib at the 2024 American Society of Hematology Annual Meeting
December 9, 2024
·
9 min read
BioCapital
Infectious Diseases Society of America Foundation Announces Applications for Microbial Pathogenesis in Alzheimer’s Research Grant
The Infectious Diseases Society of America Foundation is now accepting applications for the Microbial Pathogenesis in Alzheimer’s Disease Grant.
September 26, 2022
·
2 min read
Pharm Country
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
CorMedix Inc. today announced that two abstracts have been accepted for presentation at the Society for Healthcare Epidemiology of America (SHEA) conference being held in Houston, Texas, April 16 – 19, 2024.
April 11, 2024
·
3 min read
Press Releases
Median Technologies to Showcase AI-Powered Lung Cancer Diagnostic eyonis™ LCS at the Radiological Society of North America (RSNA) 2024
November 26, 2024
·
5 min read
Business
Lupus Foundation of America Appoints Louise Vetter as President and Chief Executive Officer
The Lupus Foundation of America, the national force devoted to solving the cruel mystery of lupus, announced the appointment of Louise Vetter as president and chief executive officer, effective July 17, 2024.
June 26, 2024
·
3 min read
Press Releases
Highly bioavailable transdermal gel from Vascarta may offer a safe and effective new way to treat sickle cell disease - presentation at American Society of Hematology Conference
December 11, 2024
·
4 min read
Drug Development
Matinas BioPharma Announces Publication of Results from the Phase 2 EnACT Clinical Trial of MAT2203 in the IDSA Journal Clinical Infectious Diseases
Matinas BioPharma announces that University of Minnesota Medical School researchers published results from the Phase 2 EnACT trial evaluating MAT2203 for the treatment of cryptococcal meningitis as a Major Article and Editor’s Choice in Clinical Infectious Diseases.
August 22, 2023
·
7 min read
Drug Development
Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the results of two Phase 2 clinical trials of Lyme disease vaccine candidate, VLA15, were published in the peer-reviewed medical journal, The Lancet Infectious Diseases.
June 3, 2024
·
7 min read
1 of 68,701
Next
